-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Theseus Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2023.
- Theseus Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$18.6M, a 142% decline year-over-year.
- Theseus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$32.9M, a 21.2% decline from 2021.
- Theseus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$27.2M, a 460% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)